Qnexa: First ever potential weight-loss pill with pros and cons

| Last updated less than one minute ago

Submit :

News Photos Just In Debate Topic Latest News Articles Local News Blog Posts Pictures Reviews Recipes

henry

14 July, 2010

Qnexa, the first potential weight-loss pill helps people shed pounds according to U.S. health regulatory staff but they are still concerned about potential safety issues.

THE FIRST potential weight-loss pill helps people shed pounds according to U.S. health regulatory staff but they are still concerned about potential safety issues.

Analysts largely shrugged off the Food and Drug Administration's concerns, and shares of Qnexa maker Vivus Inc jumped more than 15% on Tuesday, July 13, after the agency's staff said the experimental drug appeared to work.

JPMorgan analysts said in a research note that the FDA staff's assessment was "far more benign than most were expecting" and therefore was likely to boost Vivus shares.

On Thursday, an FDA panel of experts will discuss the safety issues and offer advice on whether to approve Qnexa. The agency will then make the final approval decision, which Vivus expects by October 28.

The biotechnology company wants to market the once-a-day pill for use with diet and exercise. If approved, it would be the first new U.S. prescription weight-loss drug in more than 10 years.
Anticipation of a potential new obesity drug in a nation where more than two-thirds of the people are overweight has rocked the drugmaker's shares for more than a year as anxious investors anticipate the FDA's decision.

This new potential pill might prove to be a great success if it doesn’t have much side-effect. Let us hope that it comes out with flying results as it can be revolutionary for a nation like U.S.